Nervous system affectation by COVID-19
Keywords:
coronavirus, nervous system, neurotropismAbstract
A new coronavirus was found in December 2019; later it was named SARS-CoV-2 and later the disease it produces: coronavirus disease 2019 (COVID-19). It caused in Wuhan, China, a large number of patients with respiratory symptoms and severe pneumonia with high lethality. This virus spread rapidly throughout the world causing great morbidity and mortality. Due to the neurotropic potential of this agent, various neurological disorders related to COVID-19 were reported, which could worsen the prognosis. It is highly probable that the ventilatory dysfunction of the patients is not only based on lung lesions, but also on the involvement of the cardiorespiratory center in the brain stem. It is essential to be alert to the neurological manifestations that may even occur in the early stages.
Downloads
How to Cite
Issue
Section
License
The journal Anales de la Academia de Ciencias de Cuba protects copyright, and operates with a Creative Commons License 4.0 (Creative Commons Attribution-NonCommercial License 4.0). By publishing in it, authors allow themselves to copy, reproduce, distribute, publicly communicate their work and generate derivative works, as long as the original author is cited and acknowledged. They do not allow, however, the use of the original work for commercial or lucrative purposes.
The authors authorize the publication of their writings, retaining the authorship rights, and assigning and transferring to the magazine all the rights protected by the intellectual property laws that govern in Cuba, which imply editing to disseminate the work.
Authors may establish additional agreements for the non-exclusive distribution of the version of the work published in the journal (for example, placing it in an institutional repository or publishing it in a book), with recognition of having been first published in this journal.
To learn more, see https://creativecommons.org
